在NPRL2-和NPRL3-相关的Everolimus精度治疗
Evelina Carapancea1, Erik A Eklund2, Helene Verhelst3
1Institute of NeuroScience (IoNS), Université Catholique de Louvain, Brussels, Belgium.
Epilepsia
|September 16, 2025
概括
在患有NPRL2和NPRL3相关的患者中,Everolimus有效减少了发作. 密切监测至关重要,特别是对于年轻患者,因为潜在的副作用.
科学领域:
- 遗传学和神经学 遗传学和神经学
- 药理学 药理学是指药理学的学科.
背景情况:
- 拉巴胺素 (mTOR) 途径机械标的抑制与DEPDC5,NPRL2和NPRL3基因的功能丧失变异有关,这些基因组成了GATOR1复合体.
- 作为一种mTOR抑制剂的Everolimus在DEPDC5中表现有前途,但在NPRL3中具有相互矛盾的结果.
研究的目的:
- 评估埃弗罗利斯作为NPRL2-和NPRL3-相关患者难治焦点发作的附加疗法的疗效和安全性.
主要方法:
- 四名患有NPRL2/NPRL3和难治的焦点发作的患者接受了Everolimus作为附加疗法.
- 治疗涉及每日剂量从3.75毫克到11.5毫克,监测低谷水平.
- 评估了发作频率,不良事件和治疗结果.
主要成果:
- 两名患者在两个月内完全摆脱了发作; 一名患者在较低的药物水平下出现了复发,通过剂量调整恢复.
- 另外两名患者的发作显著减少 (52%和86%).
- 副作用包括口腔炎 (导致在一个人中断治疗),高脂血症和呼吸道感染.
结论:
- 在患有NPRL2-和NPRL3-相关的患者中,Everolimus补充疗法可以显著减少发作.
- 由于潜在的不良事件,需要严格监测患者,特别是在儿科患者群体中.
相关概念视频
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
831
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
831
Epilepsy and Seizures: Overview
1.2K
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.2K
Antiepileptic Drugs: Potassium Channel Activators
635
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
635
Antiepileptic Drugs: GABAergic Pathway Potentiators
1.2K
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
1.2K
Antiepileptic Drugs: Glutamate Antagonists
902
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
902
Antiepileptic Drugs: Sodium Channel Blockers
1.6K
Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
1.6K


